PureTech Health(PTCHF)
Focus: PureTech Health is a publicly traded biotech company focused on the brain-immune-gut axis with a pipeline targeting neurology and immunology indications. The company is positioned as a clinical-stage to early commercial biotech with FDA momentum on key programs.
Profile data last refreshed 16h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Open Jobs
2+1 this month
Stable — net +1 jobs in 30d
1 added, 0 removed. Backfill posture.
Should You Work at PureTech Health?
AI assessmentBest fit for researchers and clinicians betting on emerging pipeline momentum; less suitable for those seeking immediate commercial scale or job security.
Why Work Here
- Recent FDA Fast Track designation for LYT-200 in blood cancer signals regulatory momentum and potential near-term catalysts
- Focus on brain-immune-gut axis represents a differentiated therapeutic platform with multiple shots on goal
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for PureTech Health
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.